Serial dealmaker Cathal Friel: ‘It’s important not to hand easy money to the next generation’
The Raglan Capital boss on his career and why he keeps doing deals into his 60s
Amryt Pharma
Ireland’s Mr IPO and his plans to make more companies public
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Poolbeg Pharma expands treatment into new markets
Company signs strategic collaboration agreement with a Nasdaq listed biopharma company
Upcoming Irish and overseas elections may affect M&A activity this year, William Fry warns
Falling interest rates may offer some support but acquirers are wary of policy changes here and abroad
Cathal Friel-chaired green metals company hires broker for London IPO
Flotation of Irish-run company could take place as soon as March
Life sciences a rare bright spot in muted Irish M&A activity last year - EY
Deal volumes in the Republic were down in 2023 but in value terms were up nearly 600 per cent year on year, according to EY analysis
Irish deal-making ‘muted’ amid global slump
Value of M&A transactions fell 58% to €5.2bn in first half, says William Fry
Amryt pays dividends for big investors
US funds make $79m profit on investment in Irish rare disease drug developer, and could yet make another $62.5m
Amryt strikes gold with rare-disease breakthrough
Irish pharma company secures a 100%-plus premium for shareholders in deal to sell the business to bigger Italian rival
Irish rare disease drugmaker Amryt Pharma to be acquired for up to €1.4bn
Eight-year old Amryt got EU approval last year for first treatment for rare genetic condition known as butterfly skin disease that primarily affects children
Amryt announces plan to delist from AIM in London
Drug firm says says delisting would enhance liquidity of trading
Irish pharma group Amryt reports 15% revenue growth for third quarter
Rare disease specialist says performance was ‘strong’ in ‘extremely busy’ period
Amryt Pharma granted priority review of ‘butterfly skin’ treatment
US Food and Drug Administration’s priority review can expedite review process to six months
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices